Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06451614 · ClinicalTrials.gov registry record · NA

SpaceIT Hydrogel System for Perirectal Spacing

A NA study of Prostate Cancer, sponsored by Boston Scientific Corporation.

Active
Registry status
NA
Development phase
230
Enrollment target
20
Study locations

NCT06451614 is a NA study of Prostate Cancer that is active but no longer recruiting, run by Boston Scientific Corporation. The registered enrollment target is 230 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (62% lower). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06451614, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by Boston Scientific Corporation.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
230 participants
Enrollment target
20
Study locations

Study Summary

To evaluate the safety and effectiveness of the SpaceIT™ Hydrogel System in patients undergoing External Beam Radiotherapy (EBRT) for the treatment of prostate cancer.

Conditions Studied

Prostate Cancer

Interventions

  • DEVICE SpaceIT Hydrogel System
  • DEVICE Commercially available Boston Scientific Spacer

Study Locations (20)

New York

  • Integrated Medical Professionals - New York
  • Perlmutter Cancer Center - NYU Langone - New York
  • Memorial Sloan Kettering - New York
  • Northwell Health - New York

California

  • City of Hope - Duarte
  • Orange County Urology Associates - Laguna Hills
  • Ronald Reagan UCLA Medical Center - Los Angeles

Illinois

  • Associated Urological Specialists - Chicago Ridge
  • UroPartners - Glenview
  • Springfield Clinic, LLC - Springfield

Florida

  • Baptist Hospital of Miami - Miami
  • Orlando Health Cancer Institute - Orlando

Ohio

  • University Hospitals of Cleveland-Hospital - Cleveland
  • Mercy Cancer Center Bon Secours Mercy Healt - Elyria

Pennsylvania

  • MidLantic Urology - Bala-Cynwyd
  • Perelman Center for Advanced Medicine - Philadelphia

Georgia

  • Emory University Hospital - Atlanta

Kansas

  • University of Kansas Hospital - Kansas City

Trial Details

FieldValue
Enrollment Target 230 participants
Start Date 2024-10-30
Est. Completion 2028-03-31
Phase NA

Sponsor

Boston Scientific Corporation

280 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06451614

The ClinicalTrials.gov registry entry for NCT06451614 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (62% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which SpaceIT Hydrogel System is the first listed.

NCT06451614 reports 20 study locations spanning 10 distinct geographic areas - top geographies include New York, California, Illinois.

Frequently Asked Questions

What is clinical trial NCT06451614 about?

NCT06451614 is a clinical study titled "SpaceIT Hydrogel System for Perirectal Spacing". To evaluate the safety and effectiveness of the SpaceIT™ Hydrogel System in patients undergoing External Beam Radiotherapy (EBRT) for the treatment of prostate cancer.

What is the current status of trial NCT06451614?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 230 participants. The study started on 2024-10-30. Estimated completion is 2028-03-31.

What conditions does trial NCT06451614 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT06451614?

The interventions under investigation include: SpaceIT Hydrogel System (DEVICE), Commercially available Boston Scientific Spacer (DEVICE).

Who is sponsoring clinical trial NCT06451614?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06451614 being conducted?

This trial has 20 study locations across California, Florida, Georgia, Illinois, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.